NDC 71336-1003

AMVUTTRA

Vutrisiran

AMVUTTRA is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Alnylam Pharmaceuticals, Inc.. The primary component is Vutrisiran.

Product ID71336-1003_5cff1285-ac61-47d7-a8e5-98fb52d44b27
NDC71336-1003
Product TypeHuman Prescription Drug
Proprietary NameAMVUTTRA
Generic NameVutrisiran
Dosage FormInjection
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2022-06-13
Marketing CategoryNDA /
Application NumberNDA215515
Labeler NameAlnylam Pharmaceuticals, Inc.
Substance NameVUTRISIRAN
Active Ingredient Strength25 mg/.5mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 71336-1003-1

1 SYRINGE, GLASS in 1 CARTON (71336-1003-1) > .5 mL in 1 SYRINGE, GLASS
Marketing Start Date2022-06-13
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [AMVUTTRA]

Mark Image

Registration | Serial
Company
Trademark
Application Date
AMVUTTRA
AMVUTTRA
97057480 not registered Live/Pending
Alnylam Pharmaceuticals, Inc.
2021-10-03
AMVUTTRA
AMVUTTRA
97057473 not registered Live/Pending
Alnylam Pharmaceuticals, Inc.
2021-10-03
AMVUTTRA
AMVUTTRA
90151672 not registered Live/Pending
Alnylam Pharmaceuticals, Inc.
2020-09-01

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.